When Orland Bethel walked out of UPMC after surgery that ended years of incapacitating spinal pain, he made a quiet decision: the institution that had given him back his life would have the resources to do it for thousands more. That commitment, now approaching a decade in the making, reached a new milestone in January when the Orland Bethel Family Foundation announced a $53.5 million gift to the University of Pittsburgh — a contribution that brings the family's total philanthropic investment in Pittsburgh's musculoskeletal research enterprise to nearly $100 million over five years.
The announcement is among the largest single philanthropic gifts in Pitt's history and cements the university's place at the very front of a field that affects millions of Americans living with joint disease, spinal conditions, and bone disorders. Combined with UPMC's world-class clinical infrastructure, the investment positions Pittsburgh — not Boston, not San Francisco, not Houston — as the preeminent city in musculoskeletal medicine.
The new funding will be deployed across several interconnected initiatives designed to attract and retain the highest-caliber scientific talent. Three new endowed professorships will be created within Pitt's Department of Orthopaedic Surgery, adding to the research firepower of a department already recognized internationally for its work on cartilage repair, spine surgery, and bone biology. A new "Bethel Scientists" award program will provide meaningful financial support to promising mid-career faculty — historically one of the most difficult stages to sustain in academic research, when scientists are productive enough to pursue ambitious projects but not yet senior enough to command endowment income. An endowed fund will also support executive leadership of the Bethel Musculoskeletal Research Center, ensuring administrative continuity as the center scales.
"This expansion catapults the University of Pittsburgh and UPMC to the position of world leader in this field."
University of Pittsburgh School of Medicine
Perhaps the most distinctive element of the new package is the creation of an annual Bethel Prize — an award intended to recognize thought leaders in musculoskeletal research from around the globe. Such prizes have a long history of drawing international attention to a city's scientific institutions; Pittsburgh's ability to host a globally recognized prize in orthopaedic medicine could attract collaborators, clinicians, and investment in the same way that prestigious prizes in physics and economics have shaped the reputations of the universities that host them. A new education and innovation curriculum focused on commercializing research findings rounds out the gift, a signal that the Bethel family envisions the center not only as a place where discoveries are made, but where they are translated into real treatments that reach patients.
The story behind the philanthropy is as Pittsburgh as the philanthropy itself. Orland Bethel, founder of Hillandale Farms — one of the nation's largest egg producers — spent years managing severe spinal pain before finding lasting relief through surgery at UPMC. That personal transformation became the foundation of a giving relationship that has grown with each subsequent milestone the research center achieves. The initial $2 million gift established a professorship in spine surgery; a landmark $25 million commitment in 2023 created the Bethel Musculoskeletal Research Center itself; an $18.5 million investment launched a state-of-the-art biobank. Now, the latest gift adds the structures — professorships, prizes, scientist awards, and commercialization pathways — needed to sustain excellence for generations.
For Pittsburgh, the accumulating weight of this investment matters beyond any single laboratory or clinical trial. Pitt's health sciences enterprise already accounts for more than $626 million in annual NIH funding and anchors more than 115 research centers and institutes across the university. The Bethel center represents the kind of philanthropic anchor that draws federal grants, attracts talent away from competing institutions, and makes Pittsburgh a first-call destination for patients with serious musculoskeletal conditions. In a city whose economy has spent a generation pivoting from steel to knowledge work, a world-class biomedical research hub carries real economic weight — and the Bethel family's continued confidence in Pittsburgh's future is a reminder of what ambitious philanthropy, rooted in personal gratitude, can build.